1.17

1.74% 0.02

After Hours: 1.13 -0.04 -3.42%

Rani Therapeutics Holdings Inc (RANI)

Overview News Price History Option Chain Financials Discussions Forecast

Rani Therapeutics Holdings Inc stock is traded at $1.17, with a volume of 67,747. It is up +1.74% in the last 24 hours and down -24.03% over the past month. Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Previous Close:

$1.15

Open:

$1.17

24h Volume:

67,747

Relative Volume:

0.09

Market Cap:

$41.22M

Revenue:

$3.04M

Net Income/Loss:

$-33.97M

P/E Ratio:

-0.8797

EPS:

-1.33

Net Cash Flow:

$-52.47M

1W Performance:

+3.54%

1M Performance:

-24.03%

6M Performance:

-55.51%

1Y Performance:

-85.10%

1-Day Range:

$1.11

$1.20

1-Week Range:

$1.11

$1.25

52-Week Range:

$1.03

$7.88

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name

Rani Therapeutics Holdings Inc

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

(408) 457-3700

Address

2051 RINGWOOD AVENUE, SAN JOSE

Employee

106

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

RANI's Discussions on Twitter

Compare RANI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RANI Rani Therapeutics Holdings Inc	1.17	41.22M	3.04M	-33.97M	-52.47M	-1.33
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-02-24	Initiated	Oppenheimer	Outperform
Jun-14-24	Initiated	Maxim Group	Buy
Jun-13-24	Initiated	Rodman & Renshaw	Buy
Apr-17-23	Resumed	BTIG Research	Buy
Oct-11-22	Initiated	UBS	Buy
Jul-27-22	Initiated	H.C. Wainwright	Buy
Jun-13-22	Initiated	Wedbush	Outperform

View All

Rani Therapeutics Holdings Inc Stock (RANI) Latest News

Apr 16, 2025

SEC Form DEFA14A filed by Rani Therapeutics Holdings Inc. - Quantisnow

Apr 16, 2025

Apr 05, 2025

HC Wainwright Reaffirms “Buy” Rating for Rani Therapeutics (NASDAQ:RANI) - Defense World

Apr 05, 2025

Apr 04, 2025

What is Zacks Small Cap’s Forecast for RANI FY2025 Earnings? - Defense World

Apr 04, 2025

Apr 02, 2025

Rani Therapeutics stock hits 52-week low at $1.24 - Investing.com Australia

Apr 02, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.33 Consensus PT from Analysts - Defense World

Apr 02, 2025

Apr 01, 2025

Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains - TipRanks

Apr 01, 2025

BTIG maintains Buy on Rani Therapeutics stock, $14 target - Investing.com Australia

Apr 01, 2025

RANI: 2024 Financial Results - Yahoo Finance

Apr 01, 2025

Stifel maintains Buy on Rani Therapeutics, $8 target By Investing.com - Investing.com South Africa

Apr 01, 2025

Stifel maintains Buy on Rani Therapeutics, $8 target - Investing.com

Apr 01, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

BTIG maintains Buy on Rani Therapeutics stock, $14 target By Investing.com - Investing.com UK

Apr 01, 2025

Virtu Financial LLC Invests $62,000 in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World

Apr 01, 2025

Rani Therapeutics Reports 2024 Financial Results and Updates - TipRanks

Apr 01, 2025

Mar 31, 2025

Earnings call transcript: Rani Therapeutics sees stock drop despite narrowing losses in Q4 2024 - Investing.com Canada

Mar 31, 2025

Earnings call transcript: Rani Therapeutics sees stock drop despite narrowing losses in Q4 2024 By Investing.com - Investing.com South Africa

Mar 31, 2025

Rani Therapeutics Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update - GlobeNewswire

Mar 31, 2025

Breakthrough: Rani's Oral GLP-1 Shows 111% Bioequivalence in Latest Financial Report - Stock Titan

Mar 31, 2025